KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Asset Utilization Ratio (2018 - 2026)

Aquestive Therapeutics has reported Asset Utilization Ratio over the past 8 years, most recently at 0.27 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 49.51% year-over-year to 0.27; the TTM value through Dec 2025 reached 0.27, down 49.51%, while the annual FY2025 figure was 0.34, 53.06% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.27 at Aquestive Therapeutics, down from 0.34 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.87 in Q4 2023 and troughed at 0.27 in Q4 2025.
  • A 5-year average of 0.58 and a median of 0.54 in 2024 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 131.58% in 2022 and later plummeted 49.51% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.54 in 2021, then soared by 44.24% to 0.78 in 2022, then rose by 11.14% to 0.87 in 2023, then tumbled by 37.09% to 0.54 in 2024, then plummeted by 49.51% to 0.27 in 2025.
  • Business Quant data shows Asset Utilization Ratio for AQST at 0.27 in Q4 2025, 0.34 in Q3 2025, and 0.45 in Q2 2025.